Our Corporate Milestones

World leading expertise in translational science has enabled BRIM to rapidly advance several discoveries into the clinic and successfully spin-out Ascendo Biotechnology, Inc in 2019.

Our stem cell regenerative Pigment Epithelium-Derived Factor (PEDF) derived Short Peptide (PDSP) technology platform underpins several products in our pipeline and has the potential to be effective in multiple therapy areas and indications.

Our Expertise

BRIM’s extensive experience and successful track record of translating discovery research to the clinic enables us to identify and incubate high-potential novel drug candidates through our unique drug development engine to deliver partner-ready clinical assets.

Our Core Competencies

Identifying high-potential technology
Incubating promising discoveries
Integrating diverse expertise
Innovating disease-modifying treatments
Inspiring entrepreneurial talent
Implementing efficient translational science

Mission
To advance promising discoveries into disease-modifying treatments that transform patients’ lives.

Vision
To inspire and nurture the next generation of biotech entrepreneurs to bring sustainable and affordable healthcare innovation to the world.

Values

Mentorship
Integrity
Transformation

A Team Approach to Translational Science

Contact supplier

Stay in the loop!